Polymarket
OKX IPO in 2026?
OKX IPO in 2026?
ICE · NYSE
strong_buy · 8 ratings
| Date | Firm | Action | Rating | Price target |
|---|---|---|---|---|
| July 15, 2026 | Piper Sandler | Maintains | Overweight | $190.00 |
| July 10, 2026 | Morgan Stanley | Maintains | Equal-Weight | $163.00 |
| July 9, 2026 | Barclays | Maintains | Overweight | $180.00 |
| July 7, 2026 | UBS | Maintains | Buy | $190.00 |
| June 30, 2026 | Goldman Sachs | Maintains | Buy | $180.00 |
| June 22, 2026 | TD Cowen | Maintains | Buy | $153.00 |
| May 1, 2026 | Barclays | Maintains | Overweight | $201.00 |
| April 15, 2026 | Piper Sandler | Maintains | Overweight | $211.00 |
| April 10, 2026 | Morgan Stanley | Maintains | Equal-Weight | $187.00 |
| April 8, 2026 | Barclays | Maintains | Overweight | $198.00 |
| February 10, 2026 | Morgan Stanley | Maintains | Equal-Weight | $183.00 |
| February 6, 2026 | Barclays | Maintains | Overweight | $193.00 |
| January 15, 2026 | Morgan Stanley | Maintains | Equal-Weight | $180.00 |
| January 14, 2026 | TD Cowen | Maintains | Buy | $193.00 |
| January 14, 2026 | Piper Sandler | Maintains | Overweight | $195.00 |
| January 8, 2026 | Barclays | Maintains | Overweight | $182.00 |
| January 7, 2026 | UBS | Maintains | Buy | $195.00 |
| December 22, 2025 | Morgan Stanley | Maintains | Equal-Weight | $174.00 |
| October 31, 2025 | Barclays | Maintains | Overweight | $183.00 |
| October 31, 2025 | JP Morgan | Maintains | Overweight | $180.00 |
| October 31, 2025 | TD Cowen | Maintains | Buy | $175.00 |
| October 31, 2025 | UBS | Maintains | Buy | $200.00 |
| October 21, 2025 | Morgan Stanley | Maintains | Equal-Weight | $178.00 |
| October 13, 2025 | Raymond James | Upgrades | Strong Buy | $210.00 |
| October 8, 2025 | Barclays | Maintains | Overweight | $201.00 |
| October 1, 2025 | Morgan Stanley | Maintains | Equal-Weight | $188.00 |
| September 25, 2025 | JP Morgan | Maintains | Overweight | $203.00 |
Live event probabilities associated with this company or market.
Polymarket
OKX IPO in 2026?
Polymarket
NYSE marketwide circuit breaker before 2027?
Polymarket
Aristotle
Record option volumes and the strongest U.S. cash equity volume quarter signal a constructive backdrop for ICE. Retail trading volume growth and the emergence of prediction markets are seen as ways for ICE to broaden its addressable market and sustain long-term revenue expansion.
The rise of perpetual futures is flagged as a source of lasting 'terminal value' concerns that could structurally cap valuation multiples for ICE. Significant investor focus on this competitive threat heading into Q3 keeps disruption risk firmly in view, with ICE specifically singled out as more exposed.
Despite target cuts, a broad consensus of 12 Wall Street analysts maintains a 'Moderate Buy' rating on ICE, with an average price target of $181.58 implying over 30% upside from current levels. Historical data further supports a 52-week price rise, with ICE climbing higher in 17 of the past 20 years.
Every major firm covering ICE — including TD Cowen, Goldman Sachs, UBS, Barclays, Morgan Stanley, and Piper Sandler — has reduced its price target. The modelled fair value estimate has been cut from $193.13 to $183.93, reflecting a lower future P/E multiple assumption of 27.99x versus the prior 29.45x.
ICE surpassed analyst forecasts with EPS estimates of $7.64 for FY1 and $8.38 for FY2, driven by revenue beats and disciplined expense management. Earnings and revenue are forecast to grow by 9% and 5.4% per annum respectively, underpinned by solid capital markets fundamentals and healthy fund flows.
Analysts are trimming revenue growth assumptions — from 5.84% to 5.73% — amid mixed commentary on competition and long-term growth drivers. Questions persist about how ICE should be valued as the pace of organic expansion remains modest and the competitive landscape intensifies.